Ms. Quigley has more than 25 years of clinical, regulatory and healthcare M&A and technology experience. She built the digital health and RWE group at PRA leveraging technology and data for clients from pre-clinical development through post-marketing safety and surveillance.
Her work with de-identified, patient-level data has been presented globally at the European Society for Medical Oncology/European Cancer Congress, American Society of Clinical Oncology (ASCO), American Society of Hematology, and the San Antonio Breast Cancer Symposium. She is also the author of 60+ manuscripts and abstracts and has been published in Journal of the National Comprehensive Cancer Network and The Journal of Oncology. Prior to joining PRA, Ms Quigley was a senior principal at IMS Health. She was the lead consultant for Global Oncology, partnering with clients across their oncology portfolios including pricing, market access, and regulatory requests. Prior to IMS Health, Ms Quigley was vice president at IntrinsiQ LLC. While at IntrinsiQ, she expanded their clinical consulting capabilities and worked extensively with the financial sector, including Goldman Sachs, Rodman & Renshaw, and Sanford Bernstein. Ms Quigley was the clinical nurse specialist for the Division of Hematology/Oncology at Georgetown-The Lombardi Cancer Center, director of bone marrow transplantation and peripheral blood stem cell transplantation (PBSCT). She is a member of ASCO and Oncology Nursing Society (ONS) and has a BSN from Georgetown University.
